NR0B2 and hepatocellular carcinoma: Targeted knockdown of KAT8 upregulated endogenous ERα, downregulating nuclear receptor subfamily 0 group B member 2 (NR0B2/SHP) and SMAD family member 7 (SMAD7) expression and significantly promoting HCC cell proliferation [13].